| 131.39 Net Asset Value | +3.99% 1 Day | +48.92% Year-to-Date | Overall Morningstar Rating |
| Health Style or Category | No Load Sales Expenses | 3.00% Expense Ratio | High Morningstar Risk Rating™ |
| 1 month | -5.10% | 3 years | +45.62% | |
| 3 months | +19.93% | 5 years | +21.02% | |
| 1 year | +92.32% | Since inception | +2.55% |
| BIPSX | Category | |
|---|---|---|
| Performance 5-yr return | +21.02% | +12.10% |
| Expense ratio | 3.00% | 1.54% |
| Risk 5 year sharpe ratio | 0.81 | 0.71 |
| Net assets | $271.1M | $1.6B |
| Average market cap | $30.6B | $19.4B |
| Average P/E | 24.1 | 21.6 |
| Portfolio turnover | 37% | 37% |
There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.
| Fund family | ProFunds |
| Fund manager & tenure | Hratch Najarian / 1 Years |
| Minimal initial investment | $15,000.00 |
| Minimum IRA investment | $15,000.00 |
| Other | 100.00% |
| U.S. stock | -- |
| International stock | -- |
| Fixed income | -- |
| Cash | -- |
| Healthcare | 100.00% |
| Business service | 0.00% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
| AMGN Amgen Inc | 10.13% |
| GILD Gilead Sciences Inc | 9.23% |
| ABBV AbbVie Inc | 8.97% |
| CELG Celgene Corporation | 6.48% |
| BIIB Biogen Idec Inc | 5.71% |
| ALXN Alexion Pharmaceuticals, Inc. | 2.83% |
| REGN Regeneron Pharmaceuticals, Inc. | 2.03% |
| LIFE Life Technologies Corp | 1.72% |
| VRTX Vertex Pharmaceuticals | 1.49% |
| BMRN Biomarin Pharmaceutical, Inc. | 1.06% |
.
